Basic Info

11010 Torreyana Road
San Diego, CA 92121
(858) 404-6600
Aurora Biosciences Corporation
Profile last edited on: 9/28/15
Business Identifier: Instrumentation and biological reagents for ultra high-throughput drug screening
Public Profile:
Acquird by Vertex in 2001 - itself SBIR involved in its earlier yerars - Aurora Biosciences Corporation was in the business of designing and developing proprietary drug discovery systems, services and technologies to accelerate and enhance the discovery of new medicines. Aurora had developed an integrated technology platform comprised of a portfolio of proprietary fluorescent assay technologies and an ultra-high throughput screening ("UHTS") system designed to allow assay miniaturization and to overcome many of the limitations associated with the traditional drug discovery process. From the outset, the Company entered into collaborative agreements with leading Pharma to include BMS and Lilly, licensing to them the Company's fluorescent assay technologies for their internal discovery research, to collaborate on screen development and as initial members of a syndicate to co-develop Aurora's UHTS system. In addition, Aurora entered into agreements to develop screens for or provide screening services to Sequana Therapeutics, Inc.,, Allelix Biopharmaceuticals, Inc. and Roche Bioscience, Alanex Corporation and ArQule, Inc. ("ArQule") providing Aurora with non-exclusive access to certain of their combinatorial chemistry libraries.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :